Bridging the Gap: Integrating Pharmacometrics with Quantitative Systems Pharmacology (QSP) for Smoother Clinical Phase Transitions On-Demand Webinar 填补空白:将药代动力学与定量系统药理学(QSP)相结合,以实现更顺畅的临床阶段过渡 借助行业领导者的真知灼见,掌握临床阶段的转换!Join Piet van der Graaf, SVP…Certara2024 年 1 月 2 日
Modeling and simulation in pediatric drug development Press Coverage Modeling and simulation in pediatric drug development Published: 2023 年 12 月 21 日 This is the article written in German, published on pharmind.Children's…Certara2023 年 12 月 21 日
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program Case Study 利用药代动力学建模和科学传播专长推进肉样瘤病药物项目 Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…Certara2023 年 6 月 1 日
Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease Case Study 转化药理学咨询支持治疗肺分枝杆菌复合病的联合疗法 RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…Certara2023 年 5 月 9 日
Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer Case Study Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer Bispecific antibodies are an emerging class of antibodies developed in recent years that provide new…Certara2023 年 1 月 23 日
Leveraging Clinical Data from One Rare Disease to Support Drug Approval for Another Case Study 利用一种罕见病的临床数据支持另一种罕见病的药物审批 Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare genetic disease that causes abnormal blood clot…Certara2022 年 6 月 1 日
Dose Optimization Using Population PK for an Orphan Drug Case Study Dose Optimization Using Population PK for an Orphan Drug RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…Certara2021 年 11 月 17 日